Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment.

Tsung-Ta ChiangMing-Hsien ChiangHung-Jen TangZhi-Yuan ShiMao-Wang HoChia-Hui ChouShang-Yi LinPo-Liang LuTing-Shu WuShian-Sen ShieJien-Wei LiuFeng-Yee ChangYin-Ching ChuangFu-Der WangYa-Sung Yang

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

Patients with K. pneumoniae bacteremia treated with CPZ/SUL at a ratio 1:1 had favorable outcomes when the CPZ/SUL MICs were ≤ 16 µg/ml. Patients with higher APACHE II scores and metastatic tumors had unfavorable outcomes.

Keyphrases

prognostic factors
klebsiella pneumoniae
multidrug resistant
escherichia coli
gram negative
squamous cell carcinoma
small cell lung cancer
acinetobacter baumannii
type diabetes
pseudomonas aeruginosa
glycemic control